A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast CancerSrinivasan Madhusudan, Adrian L. Harris, Trivadi S. Ganesan et al.|Clinical Cancer Research|2004Cited by 204
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|Journal of Clinical Oncology|2005Cited by 166
A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS. Muthuramalingam, Trivadi S. Ganesan, Jeremy Braybrooke et al.|Journal of Clinical Oncology|2004Cited by 2
213 A Phase Ii Study of Etanercept (ENBREL), A Tumour Necrosis Factor-Alpha Inhibitor in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|International Journal of Gynecological Cancer|2004Cited by 1
A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS. Muthuramalingam, Trivadi S. Ganesan, Jeremy Braybrooke et al.|Journal of Clinical Oncology|2004Cited by 1